By expenditures
| Name | Title | Type |
|---|---|---|
| Cathy Svetanoff | Chief Financial Officer | Auditee |
| Cheri Taylor-Lawton | Controller | Auditee |
| John Wysocki | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 358618 | 2024 | 2025-06-11 | Gw & Associates PC | $9.54M |
| 299620 | 2023 | 2024-03-28 | Gw & Associates PC | $12.33M |
| 29481 | 2022 | 2023-05-02 | Gw & Associates PC | $17.65M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 358618 | 2024 | 2025-06-11 | 1140940 | 2024-002 | Significant Deficiency | - | L |
| 358618 | 2024 | 2025-06-11 | 1140939 | 2024-001 | Significant Deficiency | Yes | E |
| 358618 | 2024 | 2025-06-11 | 1140938 | 2024-001 | Significant Deficiency | - | E |
| 358618 | 2024 | 2025-06-11 | 1140937 | 2024-003 | Significant Deficiency | Yes | L |
| 358618 | 2024 | 2025-06-11 | 1140936 | 2024-003 | Significant Deficiency | - | L |
| 358618 | 2024 | 2025-06-11 | 1140935 | 2024-003 | Significant Deficiency | - | L |
| 358618 | 2024 | 2025-06-11 | 1140934 | 2024-003 | Significant Deficiency | - | L |
| 358618 | 2024 | 2025-06-11 | 564498 | 2024-002 | Significant Deficiency | - | L |
| 358618 | 2024 | 2025-06-11 | 564497 | 2024-001 | Significant Deficiency | Yes | E |
| 358618 | 2024 | 2025-06-11 | 564496 | 2024-001 | Significant Deficiency | - | E |
| 358618 | 2024 | 2025-06-11 | 564495 | 2024-003 | Significant Deficiency | Yes | L |
| 358618 | 2024 | 2025-06-11 | 564494 | 2024-003 | Significant Deficiency | - | L |
| 358618 | 2024 | 2025-06-11 | 564493 | 2024-003 | Significant Deficiency | - | L |
| 358618 | 2024 | 2025-06-11 | 564492 | 2024-003 | Significant Deficiency | - | L |
| 299620 | 2023 | 2024-03-28 | 963911 | 2023-005 | - | - | A |
| 299620 | 2023 | 2024-03-28 | 963910 | 2023-003 | Significant Deficiency | - | E |
| 299620 | 2023 | 2024-03-28 | 963909 | 2023-004 | Material Weakness | - | L |
| 299620 | 2023 | 2024-03-28 | 963908 | 2023-004 | Material Weakness | - | L |
| 299620 | 2023 | 2024-03-28 | 963907 | 2023-004 | Material Weakness | - | L |
| 299620 | 2023 | 2024-03-28 | 963906 | 2023-002 | Material Weakness | - | C |
| 299620 | 2023 | 2024-03-28 | 963905 | 2023-002 | Material Weakness | - | C |
| 299620 | 2023 | 2024-03-28 | 963904 | 2023-002 | Material Weakness | - | C |
| 299620 | 2023 | 2024-03-28 | 963903 | 2023-006 | Significant Deficiency | - | L |
| 299620 | 2023 | 2024-03-28 | 387469 | 2023-005 | - | - | A |
| 299620 | 2023 | 2024-03-28 | 387468 | 2023-003 | Significant Deficiency | - | E |
| 299620 | 2023 | 2024-03-28 | 387467 | 2023-004 | Material Weakness | - | L |
| 299620 | 2023 | 2024-03-28 | 387466 | 2023-004 | Material Weakness | - | L |
| 299620 | 2023 | 2024-03-28 | 387465 | 2023-004 | Material Weakness | - | L |
| 299620 | 2023 | 2024-03-28 | 387464 | 2023-002 | Material Weakness | - | C |
| 299620 | 2023 | 2024-03-28 | 387463 | 2023-002 | Material Weakness | - | C |
| 299620 | 2023 | 2024-03-28 | 387462 | 2023-002 | Material Weakness | - | C |
| 299620 | 2023 | 2024-03-28 | 387461 | 2023-006 | Significant Deficiency | - | L |
| 29481 | 2022 | 2023-05-02 | 605480 | 2022-003 | Material Weakness | - | L |
| 29481 | 2022 | 2023-05-02 | 605479 | 2022-003 | Material Weakness | - | L |
| 29481 | 2022 | 2023-05-02 | 29038 | 2022-003 | Material Weakness | - | L |
| 29481 | 2022 | 2023-05-02 | 29037 | 2022-003 | Material Weakness | - | L |